Dynavax hepatitis vaccine shows promise (Hep C Chronic Fatigue)

Dynavax hepatitis vaccine shows promise
BusinessWeek - DEC. 19 9:09 A.M. ET Dynavax Technologies Corp., a biopharmaceutical focused on treatments for allergies, infectious and chronic inflammatory diseases, said Monday a mid-stage trial of its hepatitis B virus, or HBV, vaccine was successful, warranting